Adjunctive lamotrigine therapy in patients with refractory seizures: a lifetime cost-utility analysis.
Messori, A
Adjunctive lamotrigine therapy in patients with refractory seizures: a lifetime cost-utility analysis. [electronic resource] - European journal of clinical pharmacology Feb 1998 - 421-7 p. digital
Publication Type: Journal Article
0031-6970
10.1007/s002280050402 doi
Adjuvants, Pharmaceutic--economics
Adult
Anticonvulsants--economics
Cost of Illness
Cost-Benefit Analysis
Epilepsy--drug therapy
Female
Humans
Lamotrigine
Male
Prospective Studies
Quality-Adjusted Life Years
Retrospective Studies
Triazines--economics
Adjunctive lamotrigine therapy in patients with refractory seizures: a lifetime cost-utility analysis. [electronic resource] - European journal of clinical pharmacology Feb 1998 - 421-7 p. digital
Publication Type: Journal Article
0031-6970
10.1007/s002280050402 doi
Adjuvants, Pharmaceutic--economics
Adult
Anticonvulsants--economics
Cost of Illness
Cost-Benefit Analysis
Epilepsy--drug therapy
Female
Humans
Lamotrigine
Male
Prospective Studies
Quality-Adjusted Life Years
Retrospective Studies
Triazines--economics